Global Cancer Gene Therapy Market Research Report 2024
Number of Pages: 130
Category: Medical Devices & Consumables
Country: Tibet
Format:
Published Date: 10 Jan 2023
Report Overview:
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
The Global Cancer Gene Therapy Market Size was estimated at USD 621.65 million in 2023 and is projected to reach USD 1661.18 million by 2029, exhibiting a CAGR of 17.80% during the forecast period.
This report provides a deep insight into the global Cancer Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cancer Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cancer Gene Therapy market in any manner.
Global Cancer Gene Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
Market Segmentation (by Type)
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy
Market Segmentation (by Application)
Hospitals
Diagnostics Centers
Research Institutes
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Cancer Gene Therapy Market
• Overview of the regional outlook of the Cancer Gene Therapy Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Markets Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
The Global Cancer Gene Therapy Market Size was estimated at USD 621.65 million in 2023 and is projected to reach USD 1661.18 million by 2029, exhibiting a CAGR of 17.80% during the forecast period.
This report provides a deep insight into the global Cancer Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cancer Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cancer Gene Therapy market in any manner.
Global Cancer Gene Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
Market Segmentation (by Type)
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy
Market Segmentation (by Application)
Hospitals
Diagnostics Centers
Research Institutes
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Cancer Gene Therapy Market
• Overview of the regional outlook of the Cancer Gene Therapy Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Markets Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cancer Gene Therapy
1.2 Key Market Segments
1.2.1 Cancer Gene Therapy Segment by Type
1.2.2 Cancer Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cancer Gene Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Cancer Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cancer Gene Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cancer Gene Therapy Market Competitive Landscape
3.1 Global Cancer Gene Therapy Sales by Manufacturers (2019-2024)
3.2 Global Cancer Gene Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cancer Gene Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cancer Gene Therapy Sales Sites, Area Served, Product Type
3.6 Cancer Gene Therapy Market Competitive Situation and Trends
3.6.1 Cancer Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cancer Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Cancer Gene Therapy Industry Chain Analysis
4.1 Cancer Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cancer Gene Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Cancer Gene Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Gene Therapy Sales Market Share by Type (2019-2024)
6.3 Global Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Cancer Gene Therapy Price by Type (2019-2024)
7 Cancer Gene Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Gene Therapy Market Sales by Application (2019-2024)
7.3 Global Cancer Gene Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Cancer Gene Therapy Sales Growth Rate by Application (2019-2024)
8 Cancer Gene Therapy Market Segmentation by Region
8.1 Global Cancer Gene Therapy Sales by Region
8.1.1 Global Cancer Gene Therapy Sales by Region
8.1.2 Global Cancer Gene Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Cancer Gene Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cancer Gene Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cancer Gene Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cancer Gene Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cancer Gene Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Adaptimmune
9.1.1 Adaptimmune Cancer Gene Therapy Basic Information
9.1.2 Adaptimmune Cancer Gene Therapy Product Overview
9.1.3 Adaptimmune Cancer Gene Therapy Product Market Performance
9.1.4 Adaptimmune Business Overview
9.1.5 Adaptimmune Cancer Gene Therapy SWOT Analysis
9.1.6 Adaptimmune Recent Developments
9.2 Bluebird bio
9.2.1 Bluebird bio Cancer Gene Therapy Basic Information
9.2.2 Bluebird bio Cancer Gene Therapy Product Overview
9.2.3 Bluebird bio Cancer Gene Therapy Product Market Performance
9.2.4 Bluebird bio Business Overview
9.2.5 Bluebird bio Cancer Gene Therapy SWOT Analysis
9.2.6 Bluebird bio Recent Developments
9.3 Celgene
9.3.1 Celgene Cancer Gene Therapy Basic Information
9.3.2 Celgene Cancer Gene Therapy Product Overview
9.3.3 Celgene Cancer Gene Therapy Product Market Performance
9.3.4 Celgene Cancer Gene Therapy SWOT Analysis
9.3.5 Celgene Business Overview
9.3.6 Celgene Recent Developments
9.4 Shanghai Sunway Biotech
9.4.1 Shanghai Sunway Biotech Cancer Gene Therapy Basic Information
9.4.2 Shanghai Sunway Biotech Cancer Gene Therapy Product Overview
9.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Product Market Performance
9.4.4 Shanghai Sunway Biotech Business Overview
9.4.5 Shanghai Sunway Biotech Recent Developments
9.5 Shenzhen SiBiono GeneTech
9.5.1 Shenzhen SiBiono GeneTech Cancer Gene Therapy Basic Information
9.5.2 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Overview
9.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Market Performance
9.5.4 Shenzhen SiBiono GeneTech Business Overview
9.5.5 Shenzhen SiBiono GeneTech Recent Developments
9.6 SynerGene Therapeutics
9.6.1 SynerGene Therapeutics Cancer Gene Therapy Basic Information
9.6.2 SynerGene Therapeutics Cancer Gene Therapy Product Overview
9.6.3 SynerGene Therapeutics Cancer Gene Therapy Product Market Performance
9.6.4 SynerGene Therapeutics Business Overview
9.6.5 SynerGene Therapeutics Recent Developments
9.7 Altor BioScience
9.7.1 Altor BioScience Cancer Gene Therapy Basic Information
9.7.2 Altor BioScience Cancer Gene Therapy Product Overview
9.7.3 Altor BioScience Cancer Gene Therapy Product Market Performance
9.7.4 Altor BioScience Business Overview
9.7.5 Altor BioScience Recent Developments
9.8 Amgen
9.8.1 Amgen Cancer Gene Therapy Basic Information
9.8.2 Amgen Cancer Gene Therapy Product Overview
9.8.3 Amgen Cancer Gene Therapy Product Market Performance
9.8.4 Amgen Business Overview
9.8.5 Amgen Recent Developments
9.9 Argenx
9.9.1 Argenx Cancer Gene Therapy Basic Information
9.9.2 Argenx Cancer Gene Therapy Product Overview
9.9.3 Argenx Cancer Gene Therapy Product Market Performance
9.9.4 Argenx Business Overview
9.9.5 Argenx Recent Developments
9.10 BioCancell
9.10.1 BioCancell Cancer Gene Therapy Basic Information
9.10.2 BioCancell Cancer Gene Therapy Product Overview
9.10.3 BioCancell Cancer Gene Therapy Product Market Performance
9.10.4 BioCancell Business Overview
9.10.5 BioCancell Recent Developments
9.11 GlaxoSmithKline
9.11.1 GlaxoSmithKline Cancer Gene Therapy Basic Information
9.11.2 GlaxoSmithKline Cancer Gene Therapy Product Overview
9.11.3 GlaxoSmithKline Cancer Gene Therapy Product Market Performance
9.11.4 GlaxoSmithKline Business Overview
9.11.5 GlaxoSmithKline Recent Developments
9.12 Merck
9.12.1 Merck Cancer Gene Therapy Basic Information
9.12.2 Merck Cancer Gene Therapy Product Overview
9.12.3 Merck Cancer Gene Therapy Product Market Performance
9.12.4 Merck Business Overview
9.12.5 Merck Recent Developments
9.13 OncoGenex Pharmaceuticals
9.13.1 OncoGenex Pharmaceuticals Cancer Gene Therapy Basic Information
9.13.2 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Overview
9.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Market Performance
9.13.4 OncoGenex Pharmaceuticals Business Overview
9.13.5 OncoGenex Pharmaceuticals Recent Developments
9.14 Transgene
9.14.1 Transgene Cancer Gene Therapy Basic Information
9.14.2 Transgene Cancer Gene Therapy Product Overview
9.14.3 Transgene Cancer Gene Therapy Product Market Performance
9.14.4 Transgene Business Overview
9.14.5 Transgene Recent Developments
10 Cancer Gene Therapy Market Forecast by Region
10.1 Global Cancer Gene Therapy Market Size Forecast
10.2 Global Cancer Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cancer Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Cancer Gene Therapy Market Size Forecast by Region
10.2.4 South America Cancer Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cancer Gene Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Cancer Gene Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cancer Gene Therapy by Type (2025-2030)
11.1.2 Global Cancer Gene Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cancer Gene Therapy by Type (2025-2030)
11.2 Global Cancer Gene Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Cancer Gene Therapy Sales (K Units) Forecast by Application
11.2.2 Global Cancer Gene Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cancer Gene Therapy
1.2 Key Market Segments
1.2.1 Cancer Gene Therapy Segment by Type
1.2.2 Cancer Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cancer Gene Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Cancer Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cancer Gene Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cancer Gene Therapy Market Competitive Landscape
3.1 Global Cancer Gene Therapy Sales by Manufacturers (2019-2024)
3.2 Global Cancer Gene Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cancer Gene Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cancer Gene Therapy Sales Sites, Area Served, Product Type
3.6 Cancer Gene Therapy Market Competitive Situation and Trends
3.6.1 Cancer Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cancer Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Cancer Gene Therapy Industry Chain Analysis
4.1 Cancer Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cancer Gene Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Cancer Gene Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Gene Therapy Sales Market Share by Type (2019-2024)
6.3 Global Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Cancer Gene Therapy Price by Type (2019-2024)
7 Cancer Gene Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Gene Therapy Market Sales by Application (2019-2024)
7.3 Global Cancer Gene Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Cancer Gene Therapy Sales Growth Rate by Application (2019-2024)
8 Cancer Gene Therapy Market Segmentation by Region
8.1 Global Cancer Gene Therapy Sales by Region
8.1.1 Global Cancer Gene Therapy Sales by Region
8.1.2 Global Cancer Gene Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Cancer Gene Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cancer Gene Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cancer Gene Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cancer Gene Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cancer Gene Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Adaptimmune
9.1.1 Adaptimmune Cancer Gene Therapy Basic Information
9.1.2 Adaptimmune Cancer Gene Therapy Product Overview
9.1.3 Adaptimmune Cancer Gene Therapy Product Market Performance
9.1.4 Adaptimmune Business Overview
9.1.5 Adaptimmune Cancer Gene Therapy SWOT Analysis
9.1.6 Adaptimmune Recent Developments
9.2 Bluebird bio
9.2.1 Bluebird bio Cancer Gene Therapy Basic Information
9.2.2 Bluebird bio Cancer Gene Therapy Product Overview
9.2.3 Bluebird bio Cancer Gene Therapy Product Market Performance
9.2.4 Bluebird bio Business Overview
9.2.5 Bluebird bio Cancer Gene Therapy SWOT Analysis
9.2.6 Bluebird bio Recent Developments
9.3 Celgene
9.3.1 Celgene Cancer Gene Therapy Basic Information
9.3.2 Celgene Cancer Gene Therapy Product Overview
9.3.3 Celgene Cancer Gene Therapy Product Market Performance
9.3.4 Celgene Cancer Gene Therapy SWOT Analysis
9.3.5 Celgene Business Overview
9.3.6 Celgene Recent Developments
9.4 Shanghai Sunway Biotech
9.4.1 Shanghai Sunway Biotech Cancer Gene Therapy Basic Information
9.4.2 Shanghai Sunway Biotech Cancer Gene Therapy Product Overview
9.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Product Market Performance
9.4.4 Shanghai Sunway Biotech Business Overview
9.4.5 Shanghai Sunway Biotech Recent Developments
9.5 Shenzhen SiBiono GeneTech
9.5.1 Shenzhen SiBiono GeneTech Cancer Gene Therapy Basic Information
9.5.2 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Overview
9.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Market Performance
9.5.4 Shenzhen SiBiono GeneTech Business Overview
9.5.5 Shenzhen SiBiono GeneTech Recent Developments
9.6 SynerGene Therapeutics
9.6.1 SynerGene Therapeutics Cancer Gene Therapy Basic Information
9.6.2 SynerGene Therapeutics Cancer Gene Therapy Product Overview
9.6.3 SynerGene Therapeutics Cancer Gene Therapy Product Market Performance
9.6.4 SynerGene Therapeutics Business Overview
9.6.5 SynerGene Therapeutics Recent Developments
9.7 Altor BioScience
9.7.1 Altor BioScience Cancer Gene Therapy Basic Information
9.7.2 Altor BioScience Cancer Gene Therapy Product Overview
9.7.3 Altor BioScience Cancer Gene Therapy Product Market Performance
9.7.4 Altor BioScience Business Overview
9.7.5 Altor BioScience Recent Developments
9.8 Amgen
9.8.1 Amgen Cancer Gene Therapy Basic Information
9.8.2 Amgen Cancer Gene Therapy Product Overview
9.8.3 Amgen Cancer Gene Therapy Product Market Performance
9.8.4 Amgen Business Overview
9.8.5 Amgen Recent Developments
9.9 Argenx
9.9.1 Argenx Cancer Gene Therapy Basic Information
9.9.2 Argenx Cancer Gene Therapy Product Overview
9.9.3 Argenx Cancer Gene Therapy Product Market Performance
9.9.4 Argenx Business Overview
9.9.5 Argenx Recent Developments
9.10 BioCancell
9.10.1 BioCancell Cancer Gene Therapy Basic Information
9.10.2 BioCancell Cancer Gene Therapy Product Overview
9.10.3 BioCancell Cancer Gene Therapy Product Market Performance
9.10.4 BioCancell Business Overview
9.10.5 BioCancell Recent Developments
9.11 GlaxoSmithKline
9.11.1 GlaxoSmithKline Cancer Gene Therapy Basic Information
9.11.2 GlaxoSmithKline Cancer Gene Therapy Product Overview
9.11.3 GlaxoSmithKline Cancer Gene Therapy Product Market Performance
9.11.4 GlaxoSmithKline Business Overview
9.11.5 GlaxoSmithKline Recent Developments
9.12 Merck
9.12.1 Merck Cancer Gene Therapy Basic Information
9.12.2 Merck Cancer Gene Therapy Product Overview
9.12.3 Merck Cancer Gene Therapy Product Market Performance
9.12.4 Merck Business Overview
9.12.5 Merck Recent Developments
9.13 OncoGenex Pharmaceuticals
9.13.1 OncoGenex Pharmaceuticals Cancer Gene Therapy Basic Information
9.13.2 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Overview
9.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Market Performance
9.13.4 OncoGenex Pharmaceuticals Business Overview
9.13.5 OncoGenex Pharmaceuticals Recent Developments
9.14 Transgene
9.14.1 Transgene Cancer Gene Therapy Basic Information
9.14.2 Transgene Cancer Gene Therapy Product Overview
9.14.3 Transgene Cancer Gene Therapy Product Market Performance
9.14.4 Transgene Business Overview
9.14.5 Transgene Recent Developments
10 Cancer Gene Therapy Market Forecast by Region
10.1 Global Cancer Gene Therapy Market Size Forecast
10.2 Global Cancer Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cancer Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Cancer Gene Therapy Market Size Forecast by Region
10.2.4 South America Cancer Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cancer Gene Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Cancer Gene Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cancer Gene Therapy by Type (2025-2030)
11.1.2 Global Cancer Gene Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cancer Gene Therapy by Type (2025-2030)
11.2 Global Cancer Gene Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Cancer Gene Therapy Sales (K Units) Forecast by Application
11.2.2 Global Cancer Gene Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings